AAPL283.98+2.24 (+0.79%) ▲|ABBV252.87-1.44 (-0.57%) ▼|ABT92.35-0.36 (-0.39%) ▼|ACN123.06-1.68 (-1.35%) ▼|ADBE204.11-2.32 (-1.12%) ▼|AMAT719.79+25.15 (+3.62%) ▲|AMD549.63+10.14 (+1.88%) ▲|AMGN360.37-0.18 (-0.05%) ▼|AMT164.83-3.84 (-2.28%) ▼|AMZN239.40-0.74 (-0.31%) ▼|AVGO376.18+3.73 (+1.00%) ▲|AXP343.60+2.81 (+0.82%) ▲|BA216.23+1.56 (+0.73%) ▲|BAC57.18-0.70 (-1.20%) ▼|BKNG181.06-1.35 (-0.74%) ▼|BLK958.70+8.86 (+0.93%) ▲|BMY58.00-0.55 (-0.94%) ▼|BNY144.54+0.79 (+0.55%) ▲|BRK-B496.53+0.60 (+0.12%) ▲|C141.31-1.22 (-0.85%) ▼|CAT1,051.77+19.17 (+1.86%) ▲|CL91.64-0.74 (-0.80%) ▼|CMCSA24.82+0.60 (+2.48%) ▲|COF204.16+1.98 (+0.98%) ▲|COP103.92-0.28 (-0.27%) ▼|COST943.46-3.22 (-0.34%) ▼|CRM156.50-1.48 (-0.93%) ▼|CSCO118.07+0.37 (+0.31%) ▲|CVS102.99-0.59 (-0.57%) ▼|CVX167.91-0.56 (-0.33%) ▼|DE623.55-1.46 (-0.23%) ▼|DHR191.37-1.42 (-0.73%) ▼|DIS97.01-0.88 (-0.89%) ▼|DUK126.87-1.46 (-1.14%) ▼|EMR142.43-0.40 (-0.28%) ▼|FDX320.24-5.17 (-1.59%) ▼|GD349.21+1.14 (+0.33%) ▲|GE376.13+2.42 (+0.65%) ▲|GEV1,117.17+14.66 (+1.33%) ▲|GILD125.55-0.78 (-0.62%) ▼|GM77.01-0.33 (-0.43%) ▼|GOOG349.79-1.49 (-0.42%) ▼|GOOGL351.81-1.84 (-0.52%) ▼|GS1,016.28-3.93 (-0.39%) ▼|HD350.35-0.47 (-0.13%) ▼|HON227.26-0.54 (-0.24%) ▼|IBM275.70-2.30 (-0.83%) ▼|INTC134.85+3.13 (+2.38%) ▲|INTU264.76-1.65 (-0.62%) ▼|ISRG399.73-6.25 (-1.54%) ▼|JNJ256.53-1.99 (-0.77%) ▼|JPM328.55-0.85 (-0.26%) ▼|KO81.68-0.97 (-1.17%) ▼|LIN516.83+5.77 (+1.13%) ▲|LLY1,215.00-14.93 (-1.21%) ▼|LMT502.50+0.43 (+0.09%) ▲|LOW218.47-1.18 (-0.54%) ▼|LRCX433.07+22.16 (+5.39%) ▲|MA511.45+1.81 (+0.36%) ▲|MCD268.17+0.99 (+0.37%) ▲|MDLZ59.38-0.77 (-1.28%) ▼|MDT79.40-1.53 (-1.89%) ▼|META557.09-5.51 (-0.98%) ▼|MMM163.60+1.17 (+0.72%) ▲|MO73.47-0.58 (-0.78%) ▼|MRK128.38-1.01 (-0.78%) ▼|MS209.96-1.77 (-0.83%) ▼|MSFT372.00+3.43 (+0.93%) ▲|MU1,137.89-7.39 (-0.65%) ▼|NEE87.61-1.05 (-1.18%) ▼|NFLX73.43-0.35 (-0.47%) ▼|NKE41.16-0.32 (-0.77%) ▼|NOW98.42-1.56 (-1.56%) ▼|NVDA196.57+1.60 (+0.82%) ▲|ORCL148.27+0.51 (+0.35%) ▲|PEP138.38-0.30 (-0.22%) ▼|PFE24.11-0.26 (-1.08%) ▼|PG145.48-2.97 (-2.00%) ▼|PLTR116.19+0.49 (+0.42%) ▲|PM181.83-1.05 (-0.57%) ▼|QCOM187.09-1.63 (-0.86%) ▼|RTX189.04+1.71 (+0.91%) ▲|SBUX104.41+0.35 (+0.34%) ▲|SCHW93.24+2.69 (+2.97%) ▲|SO95.86-0.89 (-0.92%) ▼|SPG224.75-2.77 (-1.22%) ▼|T21.23-0.57 (-2.59%) ▼|TMO500.70-5.57 (-1.10%) ▼|TMUS169.11-4.87 (-2.80%) ▼|TSLA411.56-0.28 (-0.07%) ▼|TXN291.61+6.13 (+2.15%) ▲|UBER74.63-0.83 (-1.09%) ▼|UNH414.70-4.80 (-1.14%) ▼|UNP270.00-2.76 (-1.01%) ▼|UPS107.72-0.24 (-0.22%) ▼|USB60.67-0.59 (-0.96%) ▼|V341.34-0.35 (-0.10%) ▼|VZ43.06-1.01 (-2.30%) ▼|WFC83.26-0.24 (-0.29%) ▼|WMT113.92-0.68 (-0.59%) ▼|XOM135.63-0.41 (-0.30%) ▼|AAPL283.98+2.24 (+0.79%) ▲|ABBV252.87-1.44 (-0.57%) ▼|ABT92.35-0.36 (-0.39%) ▼|ACN123.06-1.68 (-1.35%) ▼|ADBE204.11-2.32 (-1.12%) ▼|AMAT719.79+25.15 (+3.62%) ▲|AMD549.63+10.14 (+1.88%) ▲|AMGN360.37-0.18 (-0.05%) ▼|AMT164.83-3.84 (-2.28%) ▼|AMZN239.40-0.74 (-0.31%) ▼|AVGO376.18+3.73 (+1.00%) ▲|AXP343.60+2.81 (+0.82%) ▲|BA216.23+1.56 (+0.73%) ▲|BAC57.18-0.70 (-1.20%) ▼|BKNG181.06-1.35 (-0.74%) ▼|BLK958.70+8.86 (+0.93%) ▲|BMY58.00-0.55 (-0.94%) ▼|BNY144.54+0.79 (+0.55%) ▲|BRK-B496.53+0.60 (+0.12%) ▲|C141.31-1.22 (-0.85%) ▼|CAT1,051.77+19.17 (+1.86%) ▲|CL91.64-0.74 (-0.80%) ▼|CMCSA24.82+0.60 (+2.48%) ▲|COF204.16+1.98 (+0.98%) ▲|COP103.92-0.28 (-0.27%) ▼|COST943.46-3.22 (-0.34%) ▼|CRM156.50-1.48 (-0.93%) ▼|CSCO118.07+0.37 (+0.31%) ▲|CVS102.99-0.59 (-0.57%) ▼|CVX167.91-0.56 (-0.33%) ▼|DE623.55-1.46 (-0.23%) ▼|DHR191.37-1.42 (-0.73%) ▼|DIS97.01-0.88 (-0.89%) ▼|DUK126.87-1.46 (-1.14%) ▼|EMR142.43-0.40 (-0.28%) ▼|FDX320.24-5.17 (-1.59%) ▼|GD349.21+1.14 (+0.33%) ▲|GE376.13+2.42 (+0.65%) ▲|GEV1,117.17+14.66 (+1.33%) ▲|GILD125.55-0.78 (-0.62%) ▼|GM77.01-0.33 (-0.43%) ▼|GOOG349.79-1.49 (-0.42%) ▼|GOOGL351.81-1.84 (-0.52%) ▼|GS1,016.28-3.93 (-0.39%) ▼|HD350.35-0.47 (-0.13%) ▼|HON227.26-0.54 (-0.24%) ▼|IBM275.70-2.30 (-0.83%) ▼|INTC134.85+3.13 (+2.38%) ▲|INTU264.76-1.65 (-0.62%) ▼|ISRG399.73-6.25 (-1.54%) ▼|JNJ256.53-1.99 (-0.77%) ▼|JPM328.55-0.85 (-0.26%) ▼|KO81.68-0.97 (-1.17%) ▼|LIN516.83+5.77 (+1.13%) ▲|LLY1,215.00-14.93 (-1.21%) ▼|LMT502.50+0.43 (+0.09%) ▲|LOW218.47-1.18 (-0.54%) ▼|LRCX433.07+22.16 (+5.39%) ▲|MA511.45+1.81 (+0.36%) ▲|MCD268.17+0.99 (+0.37%) ▲|MDLZ59.38-0.77 (-1.28%) ▼|MDT79.40-1.53 (-1.89%) ▼|META557.09-5.51 (-0.98%) ▼|MMM163.60+1.17 (+0.72%) ▲|MO73.47-0.58 (-0.78%) ▼|MRK128.38-1.01 (-0.78%) ▼|MS209.96-1.77 (-0.83%) ▼|MSFT372.00+3.43 (+0.93%) ▲|MU1,137.89-7.39 (-0.65%) ▼|NEE87.61-1.05 (-1.18%) ▼|NFLX73.43-0.35 (-0.47%) ▼|NKE41.16-0.32 (-0.77%) ▼|NOW98.42-1.56 (-1.56%) ▼|NVDA196.57+1.60 (+0.82%) ▲|ORCL148.27+0.51 (+0.35%) ▲|PEP138.38-0.30 (-0.22%) ▼|PFE24.11-0.26 (-1.08%) ▼|PG145.48-2.97 (-2.00%) ▼|PLTR116.19+0.49 (+0.42%) ▲|PM181.83-1.05 (-0.57%) ▼|QCOM187.09-1.63 (-0.86%) ▼|RTX189.04+1.71 (+0.91%) ▲|SBUX104.41+0.35 (+0.34%) ▲|SCHW93.24+2.69 (+2.97%) ▲|SO95.86-0.89 (-0.92%) ▼|SPG224.75-2.77 (-1.22%) ▼|T21.23-0.57 (-2.59%) ▼|TMO500.70-5.57 (-1.10%) ▼|TMUS169.11-4.87 (-2.80%) ▼|TSLA411.56-0.28 (-0.07%) ▼|TXN291.61+6.13 (+2.15%) ▲|UBER74.63-0.83 (-1.09%) ▼|UNH414.70-4.80 (-1.14%) ▼|UNP270.00-2.76 (-1.01%) ▼|UPS107.72-0.24 (-0.22%) ▼|USB60.67-0.59 (-0.96%) ▼|V341.34-0.35 (-0.10%) ▼|VZ43.06-1.01 (-2.30%) ▼|WFC83.26-0.24 (-0.29%) ▼|WMT113.92-0.68 (-0.59%) ▼|XOM135.63-0.41 (-0.30%) ▼|

23.7 C

New York

Tuesday, June 30, 2026

Group 1 Automotive Continues Nationwide Brand Alignment with Group 1 Honda South San Antonio in south San Antonio

Bluprynt and Chainproof Launch ‘Verified D&O’ Insurance for the Digital Asset Economy

Profound Launches the Profound Index at Zero Click New York, Creating the Definitive Benchmark for AI Search Visibility

Tag: accelerate

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global Sleep Apnea Devices Market, valued at US$6.4 billion in 2024 stood at US$6.9 billion in 2025...

Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global Sleep Apnea Devices Market, valued at US$6.4 billion in 2024 stood at US$6.9 billion in 2025...

Smart Factory Market worth $169.73 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global smart factory market is projected to reach USD 104.42 billion in 2025 and USD 169.73...

Smart Factory Market worth $169.73 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global smart factory market is projected to reach USD 104.42 billion in 2025 and USD 169.73...

Muscle Gain & Strength Supplements: How CrazyBulk Muscle Building Supplements Boost Strength and Maximize Muscle Performance Fast

Explore how CrazyBulk legal muscle building supplements power muscle gain, improve muscle strength, and unlock next-level muscle performance in 2025.

Explore how CrazyBulk legal muscle building supplements power muscle gain, improve muscle strength, and unlock next-level muscle performance in 2025.

Unisys Takes Meaningful Steps to Remove U.S. Pension Volatility and Accelerate Path to Full Removal

Management invites investors to webcast to discuss benefits of recent capitalstructure transformation BLUE BELL, Pa., July 18, 2025 /PRNewswire/ -- Unisys (NYSE: UIS) today announced...

HCM II Acquisition Corp. and Terrestrial Energy Announce Filing of Draft Registration Statement on Form S-4 with the SEC

CHARLOTTE, N.C. and STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) -- HCM II Acquisition Corp., (Nasdaq: HOND), (“HCM II”), a special-purpose acquisition company and Terrestrial Energy Inc., (“Terrestrial Energy”), a developer of small modular nuclear plants using advanced reactor technology, today announced the filing of the draft registration statement on Form S-4 with the U.S. Securities and Exchange Commission (“SEC”).

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsAccelerate

Group 1 Automotive Continues Nationwide Brand Alignment with Group 1 Honda South San Antonio in south San Antonio

Bluprynt and Chainproof Launch ‘Verified D&O’ Insurance for the Digital Asset Economy

Profound Launches the Profound Index at Zero Click New York, Creating the Definitive Benchmark for AI Search Visibility

Tag: accelerate

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR | MarketsandMarkets™

Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR | MarketsandMarkets™

Smart Factory Market worth $169.73 billion by 2030 – Exclusive Report by MarketsandMarkets™

Smart Factory Market worth $169.73 billion by 2030 – Exclusive Report by MarketsandMarkets™

Muscle Gain & Strength Supplements: How CrazyBulk Muscle Building Supplements Boost Strength and Maximize Muscle Performance Fast

Unisys Takes Meaningful Steps to Remove U.S. Pension Volatility and Accelerate Path to Full Removal

HCM II Acquisition Corp. and Terrestrial Energy Announce Filing of Draft Registration Statement on Form S-4 with the SEC

Lead Service Line Replacement Tool from Former EPA Flint Coordinator Now Featured in EDF & EPIC’s Lead Innovation Hub

Hexaware Acquires SMC Squared, a Leader in Building Global Capability Centers

Publicis Groupe : First Half 2025 Results

Volvo Cars reports Q2 2025 results, turnaround plan is fully on track

Essity: Interim Report Quarter 2, 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us